These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 198635)

  • 1. Antigenic variation of poliovirus caused by antibody components with different specificities.
    Urasawa S; Ishizawa F; Urasawa T
    Microbiol Immunol; 1977; 21(6):299-307. PubMed ID: 198635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies of specificity of antibodies contained in antiserum against poliovirus.
    Urasawa S; Urasawa T; Kanamitsu M
    Jpn J Microbiol; 1976 Feb; 20(1):11-6. PubMed ID: 178940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of neutralizing antibodies with different specificities to H particles of poliovirus.
    Urasawa T; Urasawa S; Taniguchi K
    Microbiol Immunol; 1979; 23(7):651-7. PubMed ID: 228166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of specificity of poliovirus inhibitors with inhibitor-resistant mutants of a strain of type 1 poliovirus.
    Hashimoto N
    J Immunol; 1975 Aug; 115(2):569-74. PubMed ID: 168261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
    Taniguchi K; Urasawa S
    Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney.
    Wiegers K; Uhlig H; Dernick R
    J Virol; 1988 May; 62(5):1845-8. PubMed ID: 2451760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary studies on antigenic variation of poliovirus using neutralizing monoclonal antibodies.
    Guo R; Tang EH; Wang H; Yang XF; Liu MY; Qin HX; Li QH; Zhuang JY; Liu KM
    J Gen Virol; 1987 Apr; 68 ( Pt 4)():989-94. PubMed ID: 3033136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.
    Pasamontes L; Egger D; Bienz K
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of escape mutants of a hybrid poliovirus with the aid of insert-specific polyclonal antibodies.
    Hovi T; Huovilainen A; Murdin A; Wimmer E
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1861-5. PubMed ID: 9049393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
    Lee CN; Kao CL; Lee CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
    Altmeyer R; Murdin AD; Harber JJ; Wimmer E
    Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.